P. Blier

发表

Reproducibility of plasma catecholamine concentrations at rest and during exercise in man

M. Volle, F. Péronnet, P. Diamond, 2004, European Journal of Applied Physiology and Occupational Physiology.

Effects of CYP2C19 and CYP2D6 gene variants on escitalopram and aripiprazole treatment outcome and serum levels: results from the CAN-BIND 1 study

Daniel J. Müller, S. Kennedy, S. Hassel, 2022, Translational Psychiatry.

International pooled patient-level meta-analysis of ketamine infusion for depression: In search of clinical moderators

M. Fava, T. Su, S. Muthukumaraswamy, 2022, Molecular Psychiatry.

Prediction of depression treatment outcome from multimodal data: a CAN-BIND-1 report.

Daniel J. Müller, S. Kennedy, S. Hassel, 2022, Psychological medicine.

The prescriber’s guide to classic MAO inhibitors (phenelzine, tranylcypromine, isocarboxazid) for treatment-resistant depression

T. Insel, J. Amsterdam, A. Beekman, 2022, CNS Spectrums.

Assessment of Objective and Subjective Cognitive Function in Patients With Treatment-Resistant Depression Undergoing Repeated Ketamine Infusions

J. Talbot, A. Ortiz, A. Van Geel, 2022, The international journal of neuropsychopharmacology.

Free-Water Diffusion Magnetic Resonance Imaging Differentiates Suicidal Ideation From Suicide Attempt in Treatment-Resistant Depression.

S. Bouix, O. Pasternak, K. Cho, 2022, Biological psychiatry. Cognitive neuroscience and neuroimaging.

Response Inhibition and Predicting Response to Pharmacological and Cognitive Behavioral Therapy Treatments for Major Depressive Disorder: A CAN-BIND Study.

S. Kennedy, G. MacQueen, B. Frey, 2022, Biological psychiatry. Cognitive neuroscience and neuroimaging.

Common Data Elements to Facilitate Sharing and Re-use of Participant-Level Data: Assessment of Psychiatric Comorbidity Across Brain Disorders

Daniel J. Müller, M. Freedman, D. Munoz, 2022, Frontiers in Psychiatry.

Treatment of maternal depression in a medication clinical trial and its effect on children.

M. Weissman, P. Wickramaratne, J. Stewart, 2015, The American journal of psychiatry.

Methodes de traitement de l'hyperhidrose idiopathique et de pathologies associees

N. Shapira, T. D. Goldsmith, P. Blier, 2004 .

SNORD90 induces glutamatergic signaling following treatment with monoaminergic antidepressants

S. Kennedy, B. Frey, R. Uher, 2023, medRxiv.

Early onset of therapeutic action in depression and greater efficacy of antidepressant treatments: are they related?

R. Bergeron, P. Blier, 1997, International clinical psychopharmacology.

ABCB1 Gene Variants and Antidepressant Treatment Outcomes: A Systematic Review and Meta‐Analysis Including Results from the CAN‐BIND‐1 Study

Daniel J. Müller, S. Kennedy, S. Hassel, 2023, Clinical pharmacology and therapeutics.

Depressive relapse following acute tryptophan depletion in patients with major depressive disorder

C. Benkelfat, R. Palmour, S. Young, 2000, Journal of psychopharmacology.

The Effects of Ketamine on Cognition in Unipolar and Bipolar Depression: A Systematic Review.

R. Lam, S. Kennedy, R. Milev, 2022, Journal of Clinical Psychiatry.

A role for the serotonin system in the mechanism of action of antidepressant treatments: preclinical evidence.

C. de Montigny, P. Blier, P. Blier, 1990, The Journal of clinical psychiatry.

Venlafaxine in treatment-resistant major depression: a Canadian multicenter, open-label trial.

G. Debonnel, C. de Montigny, P. Blier, 1999, Journal of clinical psychopharmacology.

Current advances and trends in the treatment of depression.

C. Montigny, C. de Montigny, P. Blier, 1994, Trends in pharmacological sciences.

Crosstalk between the norepinephrine and serotonin systems and its role in the antidepressant response.

P. Blier, P. Blier, 2001, Journal of psychiatry & neuroscience : JPN.

Effectiveness of pindolol with selected antidepressant drugs in the treatment of major depression.

P. Blier, R. Bergeron, P. Blier, 1995, Journal of clinical psychopharmacology.

The identification, assessment and management of difficult-to-treat depression: An international consensus statement.

A. Rush, P. Falkai, J. Soares, 2020, Journal of affective disorders.

Pharmacology of rapid-onset antidepressant treatment strategies.

P. Blier, P. Blier, 2001, The Journal of clinical psychiatry.

Electrophysiological Investigations of the Effects of a Subanesthetic Dose of Ketamine on Monoamine Systems.

P. Blier, El Iskandarani, S. Kareem, 2014 .

Putative mechanisms of action of antidepressant drugs in affective and anxiety disorders and pain.

P. Blier, F. V. Abbott, P. Blier, 2001, Journal of psychiatry & neuroscience : JPN.

Electrophysiological effects of the co-administration of escitalopram and bupropion on rat serotonin and norepinephrine neurons

P. Blier, M. Mansari, M. el Mansari, 2010, Journal of psychopharmacology.

Sustained Administration of Pramipexole Modifies the Spontaneous Firing of Dopamine, Norepinephrine, and Serotonin Neurons in the Rat Brain

P. Blier, M. Mansari, P. Blier, 2009, Neuropsychopharmacology.

Norepinephrine and selective norepinephrine reuptake inhibitors in depression and mood disorders: their pivotal roles.

P. Blier, P. Blier, 2001, Journal of psychiatry & neuroscience : JPN.

The safety of concomitant use of sumatriptan and antidepressant treatments.

P. Blier, R. Bergeron, P. Blier, 1995, Journal of clinical psychopharmacology.

The effects on children of depressed mothers' remission and relapse over 9 months

M. Weissman, M. Weissman, P. Wickramaratne, 2014, Psychological Medicine.

Plasma catecholamines at rest and exercise in subjects with high‐ and low‐trait anxiety.

M. Volle, F. Péronnet, P. Diamond, 1986, Psychosomatic medicine.

Medical assistance in living after failure of ECT and ketamine

P. Blier, S. Lafrenière, 2022, Journal of Psychiatry & Neuroscience : JPN.